Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (481-490 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S Research & Therapy|August 5, 2022
Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer's diseaseArenda Mank, Ingrid S van Maurik, Judith J M Rijnhart, et al.
Journal of Alzheimer'S Disease : JAD|December 5, 2019
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?Juhan Reimand, Colin Groot, Charlotte E Teunissen, et al.
Alzheimer'S Research & Therapy|December 8, 2019
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant casesJuhan Reimand, Arno de Wilde, Charlotte E Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical dataJetske van der Schaar, Leonie N C Visser, Johannes C F Ket, et al.
Translational Psychiatry|September 30, 2020
Immune response and endocytosis pathways are associated with the resilience against Alzheimer's diseaseNiccolò Tesi, Sven J van der Lee, Marc Hulsman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin studyJori Tomassen, Anouk den Braber, Sophie M van der Landen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 24, 2022
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic settingIngrid S van Maurik, Hana M Broulikova, Arenda Mank, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementiaNick van Wijk, Rosalinde E R Slot, Flora H Duits, et al.
Journal of the American Geriatrics Society|August 12, 2008
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) StudyAnna Poggesi, Giovanni Pracucci, Hugues Chabriat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 6, 2012
A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkersPetra E Spies, Jurgen A H R Claassen, Petronella G M Peer, et al.
Pageof 91

Showing results (481-490 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S Research & Therapy|August 5, 2022
Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer's diseaseArenda Mank, Ingrid S van Maurik, Judith J M Rijnhart, et al.
Journal of Alzheimer'S Disease : JAD|December 5, 2019
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?Juhan Reimand, Colin Groot, Charlotte E Teunissen, et al.
Alzheimer'S Research & Therapy|December 8, 2019
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant casesJuhan Reimand, Arno de Wilde, Charlotte E Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical dataJetske van der Schaar, Leonie N C Visser, Johannes C F Ket, et al.
Translational Psychiatry|September 30, 2020
Immune response and endocytosis pathways are associated with the resilience against Alzheimer's diseaseNiccolò Tesi, Sven J van der Lee, Marc Hulsman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin studyJori Tomassen, Anouk den Braber, Sophie M van der Landen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 24, 2022
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic settingIngrid S van Maurik, Hana M Broulikova, Arenda Mank, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementiaNick van Wijk, Rosalinde E R Slot, Flora H Duits, et al.
Journal of the American Geriatrics Society|August 12, 2008
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) StudyAnna Poggesi, Giovanni Pracucci, Hugues Chabriat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 6, 2012
A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkersPetra E Spies, Jurgen A H R Claassen, Petronella G M Peer, et al.
Pageof 91